Vertebrogenic low back pain is chronic back pain that originates from damaged vertebral endplates, the thin layers of cartilage and bone that sit between your vertebrae and your spinal discs. It is now recognized as a distinct structural source of chronic low back pain, separate from disc, facet joint, or sacroiliac joint problems. The pain is transmitted through a specific nerve called the basivertebral nerve, which runs through the center of each vertebral body and branches out to supply the endplates. For many people with chronic low back pain that hasn’t responded to standard treatments, vertebrogenic pain may be the overlooked cause.
How Vertebral Endplates Generate Pain
Each vertebra in your spine has a flat surface on its top and bottom called an endplate. These endplates sit right next to your spinal discs and play a key role in transferring loads across the spine and delivering nutrients to the disc. They’re innervated by pain-sensing nerve fibers, and when they become damaged, the biology gets worse in a cascading way.
As a disc degenerates, the cells inside it release inflammatory chemicals. These chemicals don’t stay contained within the disc. They seep through the endplate into the bone marrow beneath it, triggering inflammation there too. That inflammation stimulates the growth of new blood vessels and new nerve fibers into the endplate. The more damaged an endplate becomes, the denser its nerve supply gets, meaning it becomes progressively more sensitive to pain. Research has found that 90% of damaged endplates adjacent to degenerated discs show abnormal nerve ingrowth, compared with only 30% of tears in the disc’s outer wall. In other words, the endplate is often more heavily wired for pain than the disc itself.
The inflammatory chemicals also boost production of nerve growth factor in the area, which further sensitizes the pain-sensing neurons. Those neurons then release substances that cause additional inflammation, creating a self-reinforcing loop of nerve growth, sensitization, and pain. This entire process is what makes vertebrogenic pain chronic rather than something that heals and resolves on its own.
How It Differs From Other Back Pain
Chronic low back pain has traditionally been attributed to three main structural sources: the disc itself (discogenic pain), the facet joints at the back of the spine, and the sacroiliac joints in the pelvis. Vertebrogenic pain is now considered a fourth distinct source. The key distinction is where the pain signals originate and which nerve carries them. Discogenic pain comes from the outer wall of the disc and travels through small nerves on the disc’s surface. Vertebrogenic pain comes from inside the vertebral body, specifically from the endplates, and travels through the basivertebral nerve, which runs through the bone’s interior.
This distinction matters because vertebrogenic pain doesn’t respond to treatments designed for other sources. Epidural steroid injections target disc-related inflammation. Facet joint blocks target the small joints at the back of the spine. Neither addresses what’s happening inside the bone itself. For years, many patients with vertebrogenic pain were likely told their MRI looked “normal enough” or were lumped into the frustrating category of nonspecific low back pain.
How It’s Diagnosed on MRI
The identifying feature of vertebrogenic pain on imaging is something called Modic changes, which are signal abnormalities visible in the bone marrow adjacent to the endplates on MRI. Two types are relevant:
- Type 1 Modic changes indicate active inflammation and swelling in the bone marrow. On MRI, they appear dark on one type of image (T1-weighted) and bright on another (T2-weighted). These represent the more inflammatory, acute phase.
- Type 2 Modic changes indicate that the bone marrow has been replaced by fatty tissue, a sign of longer-standing degeneration. They appear bright on T1-weighted images and normal to bright on T2-weighted images.
Not everyone with Modic changes on MRI has vertebrogenic pain, but these changes are the essential imaging biomarker for identifying candidates for targeted treatment. The changes need to be present at the endplates between the L3 vertebra and the top of the sacrum (S1), which is where vertebrogenic pain most commonly occurs.
Who Is Affected
Vertebrogenic pain typically presents as deep, midline low back pain that worsens with activity and loading of the spine. It occurs in adults whose spines have finished growing, and the diagnosis requires at least six months of chronic symptoms. The pain is centered in the lower back rather than radiating down the legs, though some overlap with other conditions is possible.
Before vertebrogenic pain is considered, other common causes need to be ruled out. Conditions like spinal stenosis, disc herniation with nerve compression, spondylolisthesis (where one vertebra slips forward on another), significant scoliosis, and facet joint arthritis can all produce similar symptoms. Fractures, tumors, infections, and metabolic bone diseases like severe osteoporosis also need to be excluded.
Treatment With Basivertebral Nerve Ablation
The targeted treatment for vertebrogenic pain is basivertebral nerve ablation, a minimally invasive procedure commercially known as the Intracept procedure. The concept is straightforward: if the basivertebral nerve is carrying pain signals from damaged endplates, disabling that nerve should stop the pain.
During the procedure, you’re placed under general anesthesia and lie face down. The surgeon makes a small incision in your back and uses real-time X-ray guidance to thread a thin tube through the incision and into the vertebral body. A small channel is created to reach the trunk of the basivertebral nerve, and a radiofrequency probe delivers heat to disable the nerve. The procedure targets the specific vertebral levels where Modic changes appear on MRI.
Recovery is relatively quick. You’ll need someone to drive you home, and resting for about 48 hours while avoiding exercise is recommended. Most people fully recover within one to two weeks, which is considerably faster than traditional open back surgery.
Long-Term Results
Five-year data from three clinical studies, including a sham-controlled trial, provide the strongest evidence to date. Among 320 patients who received the procedure, 249 completed a five-year follow-up visit (a 78% participation rate, which is strong for a long-term study). At five years, the average pain score dropped by 4.3 points on a 10-point scale, and functional disability scores improved by 28 points. Seventy-eight percent of patients met the threshold for a clinically meaningful improvement in function. Both pain and functional improvements were statistically significant.
These results are notable because chronic low back pain is notoriously difficult to treat, and many interventions show benefits that fade within a year or two. The durability of relief at five years suggests the nerve ablation produces a lasting effect rather than a temporary one.
Eligibility and Coverage
The North American Spine Society (NASS) and the Centers for Medicare and Medicaid Services both recognize basivertebral nerve ablation as medically necessary for appropriate patients. To qualify, you generally need to meet all of the following criteria: you’re skeletally mature (at least 18), you’ve had chronic low back pain for at least six months with the lower back as your dominant symptom, and you’ve tried at least three conservative treatments without adequate improvement. Those treatments can include physical therapy, chiropractic care, medications (anti-inflammatories, muscle relaxants, or pain relievers), cognitive therapy, activity modification, or injection therapy for other suspected pain sources.
You also need an MRI showing Type 1 or Type 2 Modic changes at the endplates between L3 and S1, and there can’t be another spinal condition that better explains your symptoms or could complicate the procedure. A physical and psychological assessment is part of the evaluation to ensure you’re likely to benefit.
Patients with severe osteoporosis, compression fractures, spinal tumors, active infections, or significant structural problems like spondylolisthesis or spinal stenosis are generally not candidates. The procedure is designed specifically for pain coming from the endplates, so it won’t help if the pain is actually generated by a different structure.